RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      Effects on Intubating Conditions of Pretreatment with Remifentanil before Administration of Cisatracurium

      한글로보기

      https://www.riss.kr/link?id=A104269782

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Cisatracurium provides superior hemodynamic stability with only minor release of histamine,and its metabolism via Hoffman elimination is independent of organ function. However, use of cisatracurium is limited because of reportedly slower onset and uns...

      Cisatracurium provides superior hemodynamic stability with only minor release of histamine,and its metabolism via Hoffman elimination is independent of organ function.
      However, use of cisatracurium is limited because of reportedly slower onset and unsatisfactory intubating conditions. Many studies have shown that remifentanil might provide reliable intubating conditions; thus, we hypothesized that pretreatment with remifentanil before administration of cisatracurium might result in acceptable intubating conditions. Sixty healthy patients scheduled for elective surgery were enrolled and randomly divided into three groups: saline (Group I, n=20), remifentanil 0.5 μg/kg (Group II, n=20), and remifentanil 1.0 μg/kg (Group III, n=20). The anesthesia was induced with propofol 2.0 μg/kg given intravenously over 30 s followed by injection over 30 s of a different dose of remifentanil according to the study protocol. We examined the intubating condition by jaw relaxation, vocal cord state, and diaphragmatic response 90 s after administering cisatracurium. We also measured mean blood pressure,heart rate, and the onset time, which is the interval from the end of neuromuscular blocking agent administration until suppression of maximal T1 on a train-of-four sequence. The mean values of the intubating condition after endotracheal intubation in Groups II and III were significantly lower than that in Group I (p<0.005), although the overall onset time of cisatracurium did not differ significantly between the three groups. Our results suggest that supplementation with remifentanil in an induction regimen with cisatracurium improves the quality of the intubating condition even though the onset time of cisatracurium is not shortened.

      더보기

      참고문헌 (Reference)

      1 정철우, "후두경을 이용한 기관내삽관시의 심혈관계 반응을 억제하는 Remifentanil의 적정 용량" 대한마취통증의학회 49 (49): 780-785, 2005

      2 Klemola UM, "Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol" 44 : 465-469, 2000

      3 Klemola UM, "Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol" 44 : 465-469, 2000

      4 Stevens JB, "Tracheal intubation in ambulatory surgery patients: using remifentanil and propofol without muscle relaxants" 86 : 45-49, 1998

      5 van Miert MM, "The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis" 44 : 139-144, 1997

      6 Khuenl-Brady K, "The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat" 72 : 669-674, 1990

      7 Canfell PC, "The metabolic disposition of laudanosine in dog, rabbit, and man" 14 : 703-708, 1986

      8 Tan CH, "The influence of induction technique on intubating conditions 1 min after rocuronium administration: a comparison of a propofol-ephedrine combination and propofol" 57 : 223-226, 2002

      9 McKeating K, "The effects of thiopentone and propofol on upper airway integrity" 43 : 638-640, 1988

      10 Plaud B, "The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles" 95 : 96-101, 2001

      1 정철우, "후두경을 이용한 기관내삽관시의 심혈관계 반응을 억제하는 Remifentanil의 적정 용량" 대한마취통증의학회 49 (49): 780-785, 2005

      2 Klemola UM, "Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol" 44 : 465-469, 2000

      3 Klemola UM, "Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol" 44 : 465-469, 2000

      4 Stevens JB, "Tracheal intubation in ambulatory surgery patients: using remifentanil and propofol without muscle relaxants" 86 : 45-49, 1998

      5 van Miert MM, "The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis" 44 : 139-144, 1997

      6 Khuenl-Brady K, "The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat" 72 : 669-674, 1990

      7 Canfell PC, "The metabolic disposition of laudanosine in dog, rabbit, and man" 14 : 703-708, 1986

      8 Tan CH, "The influence of induction technique on intubating conditions 1 min after rocuronium administration: a comparison of a propofol-ephedrine combination and propofol" 57 : 223-226, 2002

      9 McKeating K, "The effects of thiopentone and propofol on upper airway integrity" 43 : 638-640, 1988

      10 Plaud B, "The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles" 95 : 96-101, 2001

      11 Belmont MR, "The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia" 82 : 1139-1145, 1995

      12 Sluga M, "Rocuronium versus succinylcholine for rapid sequence induction of anesthesia and endotracheal intubation: a prospective, randomized trial in emergent cases" 101 : 1356-1361, 2005

      13 Perry JJ, "Rocuronium versus succinylcholine for rapid sequence induction intubation" (2) : 2008

      14 Thompson JP, "Remifentanil-an opioid for the21st century" 76 : 341-343, 1996

      15 Egan TD, "Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers" 84 : 821-833, 1996

      16 Schwarz S, "Rapid tracheal intubation with vecuronium: the priming principle" 62 : 388-391, 1985

      17 차진욱, "Propofol 마취 유도 후 후두경을 이용한 기관내 삽관시 나타나는 혈역학반응을 둔화하기 위한 remifentanil의 적정용량" 대한마취통증의학회 51 (51): 292-296, 2006

      18 Taha S, "Propofol is superior to thiopental for intubation without muscle relaxants" 52 : 249-253, 2005

      19 Lin SP, "Priming with rocuronium to accelerate the onset time of cisatracurium during intubation" 72 : 15-19, 2009

      20 Ross AK, "Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures" 93 : 1393-1401, 2001

      21 Parker CJ, "Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis" 62 : 177-183, 1989

      22 Robertson EN, "Pharmacokinetics and pharmacodynamics of rocuronium in patients with and without renal failure" 22 : 4-10, 2005

      23 Kleinman W NG, "Neuromuscular blocking agents, In Clinical anesthesilogy. 4th ed" Lange Medical Books 205-, 2006

      24 Barker P, "Movements of the vocal cords on induction of anaesthesia with thiopentone or propofol" 69 : 23-25, 1992

      25 Mirakhur RK, "Intubating conditions after vecuronium and atracurium given in divided doses (the priming technique)" 30 : 347-350, 1986

      26 Mandal P., "Intubating conditions after cisatracurium administration: a dose response study in adults" 18 : 147-151, 2002

      27 Kisor DF, "Importance of the organ-independent elimination of cisatracurium" 83 : 1065-1071, 1996

      28 Correa CM, "Hemodynamic effects of atracurium and cisatracurium and the use of diphenhydramine and cimetidine" 60 : 52-63, 2010

      29 McAtamney D, "Evaluation of remifentanil for control of haemodynamic response to tracheal intubation" 53 : 1223-1227, 1998

      30 Bluestein LS, "Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation" 43 : 925-931, 1996

      31 Albert F, "Effects of ephedrine on the onset time of neuromuscular block and intubating conditions after cisatracurium: preliminary results" 51 : 167-171, 2000

      32 Leykin Y, "Effects of ephedrine on intubating conditions following priming with rocuronium" 49 : 792-797, 2005

      33 Kirov K, "Comparison of the neuromuscular blocking effect of cisatracurium and atracurium on the larynx and the adductor pollicis" 48 : 577-581, 2004

      34 Eames WO, "Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation" 84 : 1307-1311, 1996

      35 Cooper R, "Comparison of intubating conditions after administration of Org 9246 (rocuronium) and suxamethonium" 69 : 269-273, 1992

      36 Amin AM, "Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia" 20 : 39-51, 2009

      37 Wastila WB, "Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats" 85 : 169-177, 1996

      38 Lighthall GK, "A comparison of the onset and clinical duration of high doses of cisatracurium and rocuronium" 11 : 220-225, 1999

      39 Mellinghoff H, "A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion" 83 : 1072-1075, 1996

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2013-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2012-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2010-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.16 0.16 0.11
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.1 0.08 0.34 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼